Biomedicine and Chemical Sciences
2024, Volume 3, Issue 2 : 49-59 doi: https://doi.org/10.5281/zenodo.15773701
Research Article
Assessment of Molecular Heterogeneity of Beta-Thalassemia in Population of Karak
 ,
 ,
Received
Sept. 18, 2022
Revised
Feb. 28, 2024
Accepted
March 20, 2024
Published
April 1, 2024
Abstract

This study was designed to assess the distribution and genetic mutations of beta thalassemia in HBB gene across the district Karak. The DNA was extracted from the collected samples and gene specific point mutation was assessed using ARMS-PCR. The analysis showed the homozygosity or heterozygosity of the specific mutations (IVSI-5, CD 41-42, FSC 8-9 and CAP +15). Appropriate statistical method was used to differentiate the point mutation which is distributed in the people. Dendrogram analysis revealed variations among the studied cases. A total of three clusters were observed containing all the 46 samples (patients) based on the Euclidian distance (ranged 0-37). C-III was the biggest of all cluster as it was having 17 (36.96%) out of 46 samples while C-I and C-II was having 14 (30.43%) and 15 (32.61%) samples, respectively. Profile plot was also constructed on samples to observe the variation of each marker across all the population. It was revealed that marker IVS1-5 have values 2.3, 1.7 and 1.1 in clusters C-I, C-II and C-III respectively. Primer CD 41-42 showed values of 1.4, 2.8 and 1.2, primer FSC 8-9 had values of 1.6, 1.7 and 1.9, marker CAP 1-5 had values 2.4, 1.5 and 1.2 for C-I, C-II and C-III, respectively. Overall, the most prevalent mutation identified in this study was IVSI-5, FSC 8-9, CAP +15 and CD 41-42. It was also noted that most of the patient’s parents were not first cousin, 50% patients’ parents were second cousins. Moreover, it was observed that not proper diagnostic centers or genetic counseling centers are available at district Karak. Hence, if the government and non-governmental organizations play their role in establishment of proper pre-natal and genetic counseling centers the disease burden of the area can be minimized.

Keywords
REFERENCES
  1. Ahmed, S., Saleem, M., Modell, B., & Petrou, M. (2002). Screening extended families for genetic hemoglobin disorders in Pakistan. New England Journal of Medicine, 347(15), 1162-1168. https://doi.org/10.1056/NEJMsa013234
  2. Ali, T. T., David, J. W., & Maria, D. C. (2018). Thalassaemia [J]. Lancet, 391, 155-67.
  3. Bittles, A. H., & Black, M. L. (2010). Consanguinity, human evolution, and complex diseases. Proceedings of the National Academy of Sciences, 107(suppl_1), 1779-1786. https://doi.org/10.1073/pnas.0906079106
  4. Cai, L., Bai, H., Mahairaki, V., Gao, Y., He, C., Wen, Y., ... & Cheng, L. (2018). A universal approach to correct various HBB gene mutations in human stem cells for gene therapy of beta-thalassemia and sickle cell disease. Stem Cells Translational Medicine, 7(1), 87-97. https://doi.org/10.1002/sctm.17-0066
  5. Chan, O. T., Westover, K. D., Dietz, L., Zehnder, J. L., & Schrijver, I. (2010). Comprehensive and efficient HBB mutation analysis for detection of β-hemoglobinopathies in a pan-ethnic population. American Journal of Clinical Pathology, 133(5), 700-707. https://doi.org/10.1309/AJCP7HQ2KWGHECIO
  6. Christianson, J. C., & Green, W. N. (2004). Regulation of nicotinic receptor expression by the ubiquitin–proteasome system. The EMBO journal, 23(21), 4156-4165. https://doi.org/10.1038/sj.emboj.7600436
  7. Collins, F. S., & Weissman, S. M. (1984). The molecular genetics of human hemoglobin. Progress in Nucleic Acid Research and Molecular Biology, 31, 315-465. https://doi.org/10.1016/S0079-6603(08)60382-7
  8. Galanello, R., & Origa, R. (2012). Beta-thalassemia: Orphanet j rare dis. Journal of Continuing Education Topics & Issues, 14(1), 33-34.
  9. Higgs, D. R., & Weatherall, D. J. (2009). The alpha thalassaemias. Cellular and Molecular Life Sciences, 66, 1154-1162. https://doi.org/10.1007/s00018-008-8529-9
  10. Jalil, T., Yousafzai, Y. M., Rashid, I., Ahmed, S., Ali, A., Fatima, S., & Ahmed, J. (2019). Mutational Analysis Of Beta Thalassaemia By Multiplex Arms-Pcr In Khyber Pakhtunkhwa, Pakistan. Journal of Ayub Medical College Abbottabad-Pakistan, 31(1).
  11. Khan, N. M., Rehman, S. U., Shakeel, M., Khan, S., Ahmed, U., Rehman, H., ... & Javid, A. (2018). Molecular characterization of β-thalassemia mutations via the amplification refractory mutation system-polymerase chain reaction method at the North Waziristan Agency, Pakistan. Hemoglobin, 42(2), 91-95. https://doi.org/10.1080/03630269.2018.1487308
  12. Liaska, A., Petrou, P., Georgakopoulos, C. D., Diamanti, R., Papaconstantinou, D., Kanakis, M. G., & Georgalas, I. (2016). β-Thalassemia and ocular implications: a systematic review. BMC Ophthalmology, 16, 1-13. https://doi.org/10.1186/s12886-016-0285-2
  13. Maheen, H., Malik, F., Siddique, B., & Qidwai, A. (2015). Assessing parental knowledge about thalassemia in a thalassemia center of Karachi, Pakistan. Journal of Genetic Counseling, 24(6), 945-951. https://doi.org/10.1007/s10897-015-9830-z
  14. Maryami, F., Azarkeivan, A., Fallah, M. S., & Zeinali, S. (2015). A large cohort study of genotype and phenotype correlations of beta-thalassemia in Iranian population. International Journal of Hematology-Oncology and Stem Cell Research, 9(4), 198. https://pubmed.ncbi.nlm.nih.gov/26865931/
  15. Medrano, R. F. V., & De Oliveira, C. A. (2014). Guidelines for the tetra-primer ARMS–PCR technique development. Molecular Biotechnology, 56, 599-608. https://doi.org/10.1007/s12033-014-9734-4
  16. Mettananda, S., Suranjan, M., Fernando, R., Dias, T., Mettananda, C., Rodrigo, R., ... & Higgs, D. (2018). Anaemia among females in child-bearing age: relative contributions, effects and interactions of α-and β-thalassaemia. PloS one, 13(11), e0206928. https://doi.org/10.1371/journal.pone.0206928
  17. Modell, B., & Darlison, M. (2008). Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization, 86(6), 480-487.
  18. Muhammad, R., Shakeel, M., Rehman, S. U., & Lodhi, M. A. (2017). Population-based genetic study of β-thalassemia mutations in Mardan Division, Khyber Pakhtunkhwa Province, Pakistan. Hemoglobin, 41(2), 104-109. https://doi.org/10.1080/03630269.2017.1330210
  19. Muncie Jr, H. L., & Campbell, J. S. (2009). Alpha and beta thalassemia. American Family Physician, 80(4), 339-344.
  20. Olivieri, N. F., Pakbaz, Z., & Vichinsky, E. (2011). Hb E/beta-thalassaemia: a common & clinically diverse disorder. Indian Journal of Medical Research, 134(4), 522-531.
  21. Sadiq, M. F., Eigel, A., & Horst, J. (2001). Spectrum of β‐thalassemia in Jordan: Identification of two novel mutations. American Journal of Hematology, 68(1), 16-22. https://doi.org/10.1002/ajh.1143
  22. Shafique, F., Ali, S., Almansouri, T., Van Eeden, F., Shafi, N., Khalid, M., ... & Andleeb, S. (2021). Thalassemia, a human blood disorder. Brazilian Journal of Biology, 83, e246062. https://doi.org/10.1590/1519-6984.246062
Recommended Articles
Original Article Open Access
A FRAMEWORK OF MONOCLONAL ANTIBODIES AND RELATED PRODUCTION ENGINEERING
2025, Volume 4, Issue 4 : 26-34
Research Article Open Access
Spectroscopic and Thermal Studies of Some Palladium(II) Complexes with 2-amino-4-(4-subsistuted phenyl)thiazole Derivatives
2022, Volume 1, Issue 2 : 78-82
DOI: https://doi.org/10.48112/bcs.v1i2.104
Research Article Open Access
The Role of Vitamin D and Zinc In Facing COVID-19 Injury
2022, Volume 1, Issue 1 : 6-10
DOI: https://doi.org/10.48112/bcs.v1i1.76
Research Article Open Access
Design and Synthesis Ligands Tetradents Substituted with Halogenes in α- Position and Conjugation with Riboflavin (Bioconjugates)
2022, Volume 1, Issue 2 : 47-56
DOI: https://doi.org/10.48112/bcs.v1i2.85
Biomedicine and Chemical Sciences journal thumbnail
Volume 3, Issue 2
Citations
2 Views
0 Downloads
Share this article
License
Copyright (c) Biomedicine and Chemical Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Biomed. Chem. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Biomedicine and Chemical Sciences Logo
Biomedicine and Chemical Sciences
About Us
Biomedicine and Chemical Sciences (BCS), an international journal, publishes double blind peer-reviewed full-length, original papers, reviews or letters. BCS covers the latest developments in various fields of biomedicine such as cardiology, immunology, genetics, environmental health, neurology, oncology and toxicology
Support
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright Biomedicine and Chemical Sciences (BCS). All Rights Reserved.